Therapeutic response and survival time of immunobiologicals in patients with moderate to severe psoriasis
An. bras. dermatol
;
97(1): 112-115, Jan.-Feb. 2022. tab, graf
Article
in English
| LILACS
| ID: biblio-1360074
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Psoriasis
Limits:
Humans
Language:
English
Journal:
An. bras. dermatol
Journal subject:
Dermatology
Year:
2022
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Hospital das Clínicas da Universidade de São Paulo/BR
/
Specialty Outpatient Clinic/BR
Similar
MEDLINE
...
LILACS
LIS